Sexual dimorphism in the incidence of human cancers

Daoshan Zheng, Justyna Trynda, Cecilia Williams, Jeremy A. Vold, Justin H Nguyen, Denise Harnois, Sanjay P. Bagaria, Sarah A. McLaughlin, Zhaoyu Li

Research output: Contribution to journalArticle

Abstract

Background: Sex differences in the incidences of cancers become a critical issue in both cancer research and the development of precision medicine. However, details in these differences have not been well reported. We provide a comprehensive analysis of sexual dimorphism in human cancers. Methods: We analyzed four sets of cancer incidence data from the SEER (USA, 1975-2015), from the Cancer Registry at Mayo Clinic (1970-2015), from Sweden (1970-2015), and from the World Cancer Report in 2012. Results: We found that all human cancers had statistically significant sexual dimorphism with male dominance in the United States and mostly significant in the Mayo Clinic, Sweden, and the world data, except for thyroid cancer, which is female-dominant. Conclusions: Sexual dimorphism is a clear but mostly neglected phenotype for most human cancers regarding the clinical practice of cancer. We expect that our study will facilitate the mechanistic studies of sexual dimorphism in human cancers. We believe that fully addressing the mechanisms of sexual dimorphism in human cancers will greatly benefit current development of individualized precision medicine beginning from the sex-specific diagnosis, prognosis, and treatment.

Original languageEnglish (US)
Article number684
JournalBMC cancer
Volume19
Issue number1
DOIs
StatePublished - Jul 12 2019

Fingerprint

Sex Characteristics
Incidence
Neoplasms
Precision Medicine
Sweden
Thyroid Neoplasms
Registries
Phenotype

Keywords

  • Cancer incidence
  • Human cancers
  • Sexual dimorphism

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

Sexual dimorphism in the incidence of human cancers. / Zheng, Daoshan; Trynda, Justyna; Williams, Cecilia; Vold, Jeremy A.; Nguyen, Justin H; Harnois, Denise; Bagaria, Sanjay P.; McLaughlin, Sarah A.; Li, Zhaoyu.

In: BMC cancer, Vol. 19, No. 1, 684, 12.07.2019.

Research output: Contribution to journalArticle

Zheng, D, Trynda, J, Williams, C, Vold, JA, Nguyen, JH, Harnois, D, Bagaria, SP, McLaughlin, SA & Li, Z 2019, 'Sexual dimorphism in the incidence of human cancers', BMC cancer, vol. 19, no. 1, 684. https://doi.org/10.1186/s12885-019-5902-z
Zheng, Daoshan ; Trynda, Justyna ; Williams, Cecilia ; Vold, Jeremy A. ; Nguyen, Justin H ; Harnois, Denise ; Bagaria, Sanjay P. ; McLaughlin, Sarah A. ; Li, Zhaoyu. / Sexual dimorphism in the incidence of human cancers. In: BMC cancer. 2019 ; Vol. 19, No. 1.
@article{c92a9c3ddb4e4b8b9bb99a83713cdf2d,
title = "Sexual dimorphism in the incidence of human cancers",
abstract = "Background: Sex differences in the incidences of cancers become a critical issue in both cancer research and the development of precision medicine. However, details in these differences have not been well reported. We provide a comprehensive analysis of sexual dimorphism in human cancers. Methods: We analyzed four sets of cancer incidence data from the SEER (USA, 1975-2015), from the Cancer Registry at Mayo Clinic (1970-2015), from Sweden (1970-2015), and from the World Cancer Report in 2012. Results: We found that all human cancers had statistically significant sexual dimorphism with male dominance in the United States and mostly significant in the Mayo Clinic, Sweden, and the world data, except for thyroid cancer, which is female-dominant. Conclusions: Sexual dimorphism is a clear but mostly neglected phenotype for most human cancers regarding the clinical practice of cancer. We expect that our study will facilitate the mechanistic studies of sexual dimorphism in human cancers. We believe that fully addressing the mechanisms of sexual dimorphism in human cancers will greatly benefit current development of individualized precision medicine beginning from the sex-specific diagnosis, prognosis, and treatment.",
keywords = "Cancer incidence, Human cancers, Sexual dimorphism",
author = "Daoshan Zheng and Justyna Trynda and Cecilia Williams and Vold, {Jeremy A.} and Nguyen, {Justin H} and Denise Harnois and Bagaria, {Sanjay P.} and McLaughlin, {Sarah A.} and Zhaoyu Li",
year = "2019",
month = "7",
day = "12",
doi = "10.1186/s12885-019-5902-z",
language = "English (US)",
volume = "19",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Sexual dimorphism in the incidence of human cancers

AU - Zheng, Daoshan

AU - Trynda, Justyna

AU - Williams, Cecilia

AU - Vold, Jeremy A.

AU - Nguyen, Justin H

AU - Harnois, Denise

AU - Bagaria, Sanjay P.

AU - McLaughlin, Sarah A.

AU - Li, Zhaoyu

PY - 2019/7/12

Y1 - 2019/7/12

N2 - Background: Sex differences in the incidences of cancers become a critical issue in both cancer research and the development of precision medicine. However, details in these differences have not been well reported. We provide a comprehensive analysis of sexual dimorphism in human cancers. Methods: We analyzed four sets of cancer incidence data from the SEER (USA, 1975-2015), from the Cancer Registry at Mayo Clinic (1970-2015), from Sweden (1970-2015), and from the World Cancer Report in 2012. Results: We found that all human cancers had statistically significant sexual dimorphism with male dominance in the United States and mostly significant in the Mayo Clinic, Sweden, and the world data, except for thyroid cancer, which is female-dominant. Conclusions: Sexual dimorphism is a clear but mostly neglected phenotype for most human cancers regarding the clinical practice of cancer. We expect that our study will facilitate the mechanistic studies of sexual dimorphism in human cancers. We believe that fully addressing the mechanisms of sexual dimorphism in human cancers will greatly benefit current development of individualized precision medicine beginning from the sex-specific diagnosis, prognosis, and treatment.

AB - Background: Sex differences in the incidences of cancers become a critical issue in both cancer research and the development of precision medicine. However, details in these differences have not been well reported. We provide a comprehensive analysis of sexual dimorphism in human cancers. Methods: We analyzed four sets of cancer incidence data from the SEER (USA, 1975-2015), from the Cancer Registry at Mayo Clinic (1970-2015), from Sweden (1970-2015), and from the World Cancer Report in 2012. Results: We found that all human cancers had statistically significant sexual dimorphism with male dominance in the United States and mostly significant in the Mayo Clinic, Sweden, and the world data, except for thyroid cancer, which is female-dominant. Conclusions: Sexual dimorphism is a clear but mostly neglected phenotype for most human cancers regarding the clinical practice of cancer. We expect that our study will facilitate the mechanistic studies of sexual dimorphism in human cancers. We believe that fully addressing the mechanisms of sexual dimorphism in human cancers will greatly benefit current development of individualized precision medicine beginning from the sex-specific diagnosis, prognosis, and treatment.

KW - Cancer incidence

KW - Human cancers

KW - Sexual dimorphism

UR - http://www.scopus.com/inward/record.url?scp=85068997038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068997038&partnerID=8YFLogxK

U2 - 10.1186/s12885-019-5902-z

DO - 10.1186/s12885-019-5902-z

M3 - Article

VL - 19

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 684

ER -